Akon Health Empowers Chain Pharmacies with Light-Model DTP Transformation and Strengthens Pharmaceutical Supply Chain

On September 27, 2018, at the VCBeat 2018 MedTech World Forum Gala, Akang Health won the “Pharmaceutical Digital Marketing Award” and the “Most Popular Award” in the category of Outstanding Digital Healthcare Collaboration Cases, recognized for its strong online popularity and high reputation in internet-driven innovative development.

VCBeat Founder Li Datao (first from left) presents the 2018 Outstanding Digital Health Case Award to Akang Health

“Pharmaceutical Digital Marketing Award” and “Most Popular Award”

A-Kang Health’s development goal is to ensure that no one struggles to find the medications they need. Openness, inclusivity, and keeping pace with the times are inherent to A-Kang Health’s corporate culture. Aligning with industry trends, A-Kang Health has leveraged its strength in “integrated supply chain services for 12,000 off-hospital prescription drugs focused on chronic diseases, critical conditions, and rare diseases” in its B-side services. With the aim of promoting the development of new off-hospital prescription drug marketplaces, the company has established a core business model represented by “customer-proxy medication ordering,” achieving leapfrog growth. It has assisted over 600 chain pharmacies in transitioning to an asset-light DTP (Direct-to-Patient) prescription drug operation model, provided medication-search tools to more than 30,000 pharmacists, and cumulatively resolved medication access difficulties for 3.9 million chronic disease patients across Chinese households.

This selection has once again drawn significant attention and acclaim from the industry for Aikang Health’s development platform. Aikang Health also stated that, in alignment with the national goal of ensuring “minor illnesses are treated at the township level and major illnesses within the county,” it has comprehensively expanded its systemic framework for chronic disease rehabilitation. In 2019, the company will vigorously advance and strategically deploy this initiative, collaborating with primary healthcare institutions across China and B-side commercial service platforms—represented by its first strategic partner, “Rongyao Online”—to jointly promote innovative developments aimed at enhancing primary healthcare service capabilities. Through resource complementarity and strong alliances among social enterprises, Aikang Health is committed to enabling the effective delivery of chronic disease rehabilitation services at the grassroots level.

In the future, Aikang Health will continue to innovate through internet-based tools, fully opening and sharing its prescription drug supply chain to foster the development of an emerging out-of-hospital market for prescription medications. This initiative aims to empower partners—including primary healthcare providers, retail pharmacies, commercial distributors, internet healthcare platforms, and health testing companies—to optimize prescription drug operations and enhance chronic disease management capabilities. We remain committed to our mission: ensuring that no one struggles to find the medication they need.

This article is a collaborative piece, with content provided by the enterprise.